AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11729332 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.625 mg conjugated equine estrogen (CEE) and 2.5 mg medroxyprogesterone acetate (MPA) every-other-day
Number of subjects: 21
Study 11729332 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 21
Study 9145087 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrient and food intakes of infants
Number of subjects: 94
Study 9145087 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat intake
Number of subjects: 94
Study 9145087 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced-fat milks consumption
Number of subjects: 94
Study 9145087 — intervention group
Group type: EXPERIMENTAL
Intervention: Variety of foods consumed
Number of subjects: 94
Study 9145087 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium intake from dairy products
Number of subjects: 94
Study 9145087 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional issues identified
Number of subjects: 94
Study 8130395 — intervention group
Group type: EXPERIMENTAL
Intervention: Transverse process fusion with autogenous iliac crest bone graft and instrumentation (Group III)
Number of subjects: 43
Study 8130395 — intervention group
Group type: COMPARATOR
Intervention: No fusion (Group I)
Number of subjects: 43
Study 8130395 — intervention group
Group type: COMPARATOR
Intervention: Transverse process fusion without instrumentation (Group II)
Number of subjects: 43
Study 8130395 — intervention group
Group type: EXPERIMENTAL
Intervention: Spondylolisthesis unchanged subjects
Number of subjects: 43
Study 3119340 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin (0.5 mg)
Number of subjects: 16
Study 3119340 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 27966192 — intervention group
Group type: EXPERIMENTAL
Intervention: SDM intervention (12-h SDM training program for physicians in combination with decision board use)
Number of subjects: 107
Study 27966192 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients treated by SDM-trained physicians
Number of subjects: 107
Study 27966192 — intervention group
Group type: EXPERIMENTAL
Intervention: SDM intervention
Number of subjects: 107
Study 27595402 — intervention group
Group type: EXPERIMENTAL
Intervention: Transperineal prostatic block (TPPB) with 10 ml 2% prilocaine (Group-I)
Number of subjects: 376
Study 27595402 — intervention group
Group type: COMPARATOR
Intervention: Intrarectal lidocaine gel (10 ml 2% lidocaine) followed by periprostatic nerve blockage (PPNB) with 10 ml 2% prilocaine (Group-II)
Number of subjects: 376
Study 23877377 — intervention group
Group type: EXPERIMENTAL
Intervention: EX60 (60 min of moderate treadmill exercise at 56% peak V˙O2)
Number of subjects: 18
Study 22068425 — intervention group
Group type: EXPERIMENTAL
Intervention: AAV2.5 vector injected into the bicep muscle
Number of subjects: 0
Study 22068425 — intervention group
Group type: COMPARATOR
Intervention: Saline control injected into the contralateral arm
Number of subjects: 0
Study 22068425 — intervention group
Group type: EXPERIMENTAL
Intervention: AAV empty capsid
Number of subjects: 0
Study 20466473 — intervention group
Group type: EXPERIMENTAL
Intervention: Alveolar distraction osteogenesis
Number of subjects: 12
Study 20466473 — intervention group
Group type: COMPARATOR
Intervention: Sandwich osteotomy technique and tibial bone grafting
Number of subjects: 12
Study 18689371 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily 500 mcg phylloquinone supplementation for 3 years
Number of subjects: 379
Study 18689371 — intervention group
Group type: COMPARATOR
Intervention: Control group (no phylloquinone supplementation)
Number of subjects: 379
Study 18689371 — intervention group
Group type: EXPERIMENTAL
Intervention: Phylloquinone supplementation
Number of subjects: 379
Study 15711432 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 31
Study 15711432 — intervention group
Group type: COMPARATOR
Intervention: Fluvoxamine
Number of subjects: 31
Study 15331394 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (HA) + oral placebo
Number of subjects: 301
Study 15331394 — intervention group
Group type: EXPERIMENTAL
Intervention: Diacerein 100 mg/day + IA injections of saline solution
Number of subjects: 301
Study 15331394 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral placebo + IA injections of saline solution
Number of subjects: 301
Study 11425926 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-beta-1a, 22 mcg tiw
Number of subjects: 339
Study 11425926 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-beta-1a, 44 mcg tiw
Number of subjects: 339
Study 11425926 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 339
Study 9402534 — intervention group
Group type: EXPERIMENTAL
Intervention: Sarin cases (exposed to sarin)
Number of subjects: 18
Study 9402534 — intervention group
Group type: COMPARATOR
Intervention: Matched controls
Number of subjects: 18
Study 8352372 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-ASA enemas
Number of subjects: 14
Study 8352372 — intervention group
Group type: COMPARATOR
Intervention: Placebo enemas
Number of subjects: 14
Study 2441162 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg S-9780
Number of subjects: 8
Study 2441162 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg S-9780
Number of subjects: 8
Study 2441162 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg S-9780
Number of subjects: 8
Study 2441162 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 31750699 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based yogic breathing (MB)
Number of subjects: 60
Study 31750699 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive strategy (CS)
Number of subjects: 60
Study 31750699 — intervention group
Group type: COMPARATOR
Intervention: No-treatment (NT)
Number of subjects: 60
Study 29030287 — intervention group
Group type: EXPERIMENTAL
Intervention: Heterotopic noxious counter-stimulation (HNCS)
Number of subjects: 17
Study 29030287 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective attention
Number of subjects: 17
Study 29030287 — intervention group
Group type: EXPERIMENTAL
Intervention: Heterotopic noxious counter-stimulation (HNCS) with attention directed toward the HNCS stimulus
Number of subjects: 17
Study 28484897 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary vitamin E supplementation at 50 mg/kg
Number of subjects: 3
Study 28484897 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary vitamin E supplementation at 100 mg/kg
Number of subjects: 3
Study 28484897 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary vitamin E supplementation at 300 mg/kg
Number of subjects: 3
Study 28484897 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary vitamin E supplementation at 500 mg/kg
Number of subjects: 3
Study 28484897 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary vitamin E supplementation at 56.3 mg/kg
Number of subjects: 3
Study 28484897 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary vitamin E supplementation (incremental levels)
Number of subjects: 3
Study 28484897 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary vitamin E supplementation from 56.3 to 588.4 mg/kg
Number of subjects: 3
Study 26559363 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment for depression group
Number of subjects: 100
Study 26559363 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment for schizophrenia group
Number of subjects: 100
Study 26559363 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 100
Study 24474233 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesalazine (Pentasa®) 2 g sachet once daily
Number of subjects: 0
Study 24474233 — intervention group
Group type: COMPARATOR
Intervention: Mesalazine (twice daily in tablets)
Number of subjects: 0
Study 21199957 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion treatment for 8 weeks
Number of subjects: 30
Study 21199957 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment for 8 weeks
Number of subjects: 30
Study 18457235 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent Insomnia
Number of subjects: 1801
Study 18457235 — intervention group
Group type: COMPARATOR
Intervention: Usual care for depression
Number of subjects: 1801
Study 18457235 — intervention group
Group type: COMPARATOR
Intervention: Enhanced care for depression
Number of subjects: 1801
Study 18457235 — intervention group
Group type: COMPARATOR
Intervention: No Insomnia
Number of subjects: 1801
Study 18457235 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate Insomnia
Number of subjects: 1801
Study 16551141 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (n=80): 12-week parenting course (Incredible Years) and co-parenting component
Number of subjects: 128
Study 16551141 — intervention group
Group type: COMPARATOR
Intervention: Control (n=48): Usual care
Number of subjects: 128
Study 14560767 — intervention group
Group type: EXPERIMENTAL
Intervention: Spectral analysis
Number of subjects: 78
Study 14560767 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling analysis
Number of subjects: 78
Study 10919933 — intervention group
Group type: EXPERIMENTAL
Intervention: High-isoflavone dietary treatment
Number of subjects: 24
Study 10919933 — intervention group
Group type: COMPARATOR
Intervention: Low-isoflavone dietary treatment
Number of subjects: 24
Study 8960603 — intervention group
Group type: EXPERIMENTAL
Intervention: Echocardiographic automated boundary detection (ABD)
Number of subjects: 0
Study 8960603 — intervention group
Group type: COMPARATOR
Intervention: Conventional manual echocardiographic methods
Number of subjects: 0
Study 1404628 — intervention group
Group type: EXPERIMENTAL
Intervention: Intussuscepted nipple valve
Number of subjects: 40
Study 1404628 — intervention group
Group type: COMPARATOR
Intervention: Le Duc mucosal trough technique
Number of subjects: 40
Study 3905342 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 40
Study 31922372 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic seizure therapy (high frequency 100 Hz, medium frequency 50 or 60 Hz, low frequency 25 Hz)
Number of subjects: 26
Study 31922372 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic seizure therapy (high frequency over vertex)
Number of subjects: 26
Study 31922372 — intervention group
Group type: COMPARATOR
Intervention: Cognitive measures
Number of subjects: 26
Study 31741561 — intervention group
Group type: EXPERIMENTAL
Intervention: Local infiltration anaesthesia with 2% lidocaine and epinephrine 1/100000 (LA)
Number of subjects: 60
Study 31741561 — intervention group
Group type: COMPARATOR
Intervention: 0.25% levobupivacaine (LB)
Number of subjects: 60
Study 28095051 — intervention group
Group type: EXPERIMENTAL
Intervention: Group intervention and workbook
Number of subjects: 12
Study 28095051 — intervention group
Group type: COMPARATOR
Intervention: Workbook only (Control)
Number of subjects: 12
Study 28095051 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Treatment and Control)
Number of subjects: 12
Study 28095051 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment group
Number of subjects: 12
Study 25873530 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight management group (dietary and exercise program)
Number of subjects: 120
Study 25873530 — intervention group
Group type: COMPARATOR
Intervention: Control group (health education)
Number of subjects: 120
Study 23703424 — intervention group
Group type: EXPERIMENTAL
Intervention: Painful pressure stimulus of 1,500 kPa applied to the middle phalanx of the right middle finger
Number of subjects: 96
Study 23703424 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate to severe anxiety
Number of subjects: 96
Study 23703424 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender comparison (Men vs Women)
Number of subjects: 96
Study 23703424 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender and anxiety level
Number of subjects: 96
Study 21144659 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency TENS (4Hz)
Number of subjects: 100
Study 21144659 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency TENS (100Hz)
Number of subjects: 100
Study 21144659 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 21144659 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 100
Study 21144659 — intervention group
Group type: EXPERIMENTAL
Intervention: DNIC (Diffuse noxious inhibitory control)
Number of subjects: 100
Study 19481687 — intervention group
Group type: EXPERIMENTAL
Intervention: Testopatch applied on thigh
Number of subjects: 24
Study 19481687 — intervention group
Group type: EXPERIMENTAL
Intervention: Testopatch applied on upper arm
Number of subjects: 24
Study 19481687 — intervention group
Group type: EXPERIMENTAL
Intervention: Testopatch at 2.0 h
Number of subjects: 24
Study 19481687 — intervention group
Group type: EXPERIMENTAL
Intervention: Testopatch at lower back
Number of subjects: 24
Study 19481687 — intervention group
Group type: EXPERIMENTAL
Intervention: Testopatch
Number of subjects: 24
Study 16473376 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity intervention
Number of subjects: 842
Study 16473376 — intervention group
Group type: COMPARATOR
Intervention: Non-participants (non-volunteers)
Number of subjects: 842
Study 15109188 — intervention group
Group type: EXPERIMENTAL
Intervention: Vital capacity rapid inhalation induction at 8% sevoflurane (Group VC8)
Number of subjects: 125
Study 15109188 — intervention group
Group type: EXPERIMENTAL
Intervention: Vital capacity rapid inhalation induction at 4.5% sevoflurane (Group VC4.5)
Number of subjects: 125
Study 15109188 — intervention group
Group type: COMPARATOR
Intervention: Conventional stepwise inhalation induction (Group C)
Number of subjects: 125
Study 11687365 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical anesthesia
Number of subjects: 75
Study 11687365 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical plus intracameral anesthesia
Number of subjects: 75
Study 11687365 — intervention group
Group type: COMPARATOR
Intervention: No anesthesia
Number of subjects: 75
Study 9174114 — intervention group
Group type: EXPERIMENTAL
Intervention: LY293111 48 mg
Number of subjects: 20
Study 9174114 — intervention group
Group type: EXPERIMENTAL
Intervention: LY293111 200 mg
Number of subjects: 20
Study 9174114 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 9174114 — intervention group
Group type: EXPERIMENTAL
Intervention: LY293111
Number of subjects: 20
Study 7697690 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg/d for 4 weeks
Number of subjects: 156
Study 7697690 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg/d for 4 weeks
Number of subjects: 156
Study 7697690 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg/d for 6 months
Number of subjects: 156
Study 7697690 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg every other day for 6 months
Number of subjects: 156
Study 7697690 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (both doses)
Number of subjects: 156
Study 3310639 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium carbonate (800 mg elemental calcium per day)
Number of subjects: 26
Study 3310639 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium citrate (800 mg elemental calcium per day)
Number of subjects: 26
Study 3310639 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 3310639 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium carbonate
Number of subjects: 26
Study 3310639 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium citrate
Number of subjects: 26
Study 31102684 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Circuit Training (HICT)
Number of subjects: 33
Study 31102684 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 33
Study 28603176 — intervention group
Group type: EXPERIMENTAL
Intervention: BM-MNC implantation
Number of subjects: 38
Study 28603176 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 38
Study 28603176 — intervention group
Group type: EXPERIMENTAL
Intervention: BM-MNC treatment
Number of subjects: 38
Study 28603176 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary endpoints (pain, ulcers, TcPO2, ankle-brachial index)
Number of subjects: 38
Study 24176229 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg choline daily for 9 months
Number of subjects: 20
Study 24176229 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 21644310 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger-partition moxibustion
Number of subjects: 43
Study 21644310 — intervention group
Group type: COMPARATOR
Intervention: Suspended moxibustion
Number of subjects: 43
Study 21644310 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger-partition moxibustion at Shengshu (BL 23)
Number of subjects: 43
Study 18077211 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal continuous positive airway pressure (nCPAP) treatment
Number of subjects: 46
Study 18077211 — intervention group
Group type: COMPARATOR
Intervention: Control group (subjects without OSA and with mild OSA)
Number of subjects: 46
Study 16963674 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic nCPAP (optimal pressure, n = 15)
Number of subjects: 25
Study 16963674 — intervention group
Group type: COMPARATOR
Intervention: Sham nCPAP (suboptimal pressure of 1 to 2 cm H2O, n = 10)
Number of subjects: 25
Study 15309692 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous milrinone
Number of subjects: 949
Study 15309692 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 949
Study 15309692 — intervention group
Group type: EXPERIMENTAL
Intervention: Arrhythmia group
Number of subjects: 949
Study 15309692 — intervention group
Group type: COMPARATOR
Intervention: No arrhythmia group
Number of subjects: 949
Study 12915605 — intervention group
Group type: EXPERIMENTAL
Intervention: Consolidation workshops (6 sessions of 3 hours each after basic training)
Number of subjects: 63
Study 12915605 — intervention group
Group type: COMPARATOR
Intervention: Waiting list (control group)
Number of subjects: 63
Study 9864075 — intervention group
Group type: COMPARATOR
Intervention: Fluvoxamine 300 mg/day + Placebo
Number of subjects: 72
Study 9864075 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine 300 mg/day + Pindolol 7.5 mg/day
Number of subjects: 72
Study 9864075 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine + Pindolol
Number of subjects: 72
Study 7838642 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid injection of indomethacin (3 doses)
Number of subjects: 18
Study 7838642 — intervention group
Group type: COMPARATOR
Intervention: Continuous intravenous infusion of indomethacin (over 36 hours)
Number of subjects: 18
Study 2146697 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 0
Study 2146697 — intervention group
Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 0
Study 2146697 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 687017 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term extracorporeal membrane oxygenation (ECMO)
Number of subjects: 90
Study 687017 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy without ECMO
Number of subjects: 90
Study 31418062 — intervention group
Group type: EXPERIMENTAL
Intervention: Early initiation of dialysis
Number of subjects: 0
Study 31418062 — intervention group
Group type: COMPARATOR
Intervention: Late initiation of dialysis
Number of subjects: 0
Study 31159495 — intervention group
Group type: EXPERIMENTAL
Intervention: Nordic diet group (NG)
Number of subjects: 250
Study 31159495 — intervention group
Group type: COMPARATOR
Intervention: Conventional diet group (CG)
Number of subjects: 250
Study 27669162 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma-focused cognitive behavior therapy (CBT)
Number of subjects: 33
Study 27669162 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma-focused cognitive therapy (CT)
Number of subjects: 33
Study 25467199 — intervention group
Group type: EXPERIMENTAL
Intervention: Run/walk strategy
Number of subjects: 42
Study 25467199 — intervention group
Group type: COMPARATOR
Intervention: Running only
Number of subjects: 42
Study 25467199 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Run/walk and Running only)
Number of subjects: 42
Study 25257273 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug therapy (oral antibiotics, mometasone furoate nasal spray, leukotriene receptor antagonist, mucoactive medications) for 3 months
Number of subjects: 386
Study 25257273 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative treatment (drug therapy plus negative pressure of sputum aspiration) for 3 months
Number of subjects: 386
Study 25257273 — intervention group
Group type: EXPERIMENTAL
Intervention: Coblation adenotonsillectomy after 3 days conservative treatment and postoperative drug therapy for 2 weeks (B2 subgroup)
Number of subjects: 386
Study 25257273 — intervention group
Group type: EXPERIMENTAL
Intervention: Coblation adenotonsillectomy after 2 weeks conservative treatment and postoperative drug therapy for 3 months (B3 subgroup)
Number of subjects: 386
Study 25257273 — intervention group
Group type: COMPARATOR
Intervention: Drug therapy for 3 months (A1 subgroup)
Number of subjects: 386
Study 25257273 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment for 3 months (B1 subgroup)
Number of subjects: 386
Study 22889492 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentraxin-3 levels in women with primary unexplained recurrent pregnancy loss
Number of subjects: 90
Study 22889492 — intervention group
Group type: COMPARATOR
Intervention: Pentraxin-3 levels in apparently healthy pregnant women
Number of subjects: 90
Study 19666456 — intervention group
Group type: EXPERIMENTAL
Intervention: Active-online (tailored intervention)
Number of subjects: 1531
Study 19666456 — intervention group
Group type: EXPERIMENTAL
Intervention: Active-online (tailored intervention) and spontaneous users
Number of subjects: 1531
Study 19666456 — intervention group
Group type: COMPARATOR
Intervention: Nontailored website (control group)
Number of subjects: 1531
Study 17766475 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill exercise in a lower body negative pressure chamber and resistance exercise (EX group)
Number of subjects: 16
Study 17766475 — intervention group
Group type: COMPARATOR
Intervention: No exercise (No-EX group)
Number of subjects: 16